Title:
|
CNS CLINICAL TRIALS
SUICIDALITY AND DATA COLLECTION: WORKSHOP SUMMARY |
By: |
Forum on Neuroscience and Nervous System Disorders, Board on Health Sciences Policy, Institute of Medicine |
Format: |
Paperback |
List price:
|
£13.99 |
We believe that this item is permanently unavailable, and so we cannot source
it.
|
|
|
|
|
ISBN 10: |
0309148839 |
ISBN 13: |
9780309148832 |
Publisher: |
NATIONAL ACADEMIES PRESS |
Pub. date: |
22 December, 2010 |
Pages: |
88 |
Description: |
"The Food and Drug Administration (FDA) now requires that all clinical trials for drugs that affect the central nervous system--including psychiatric drugs--are assessed for whether that drug might cause suicidal ideation or behavior. The Institute of Medicine's (IOM) Forum on Neuroscience and Nervous System Disorders hosted a meeting on June 26, 2009, to discuss the FDA's new policy and how to analyze best whether suicidal thoughts predict actual suicidal behavior in the near future."--Publisher's description. |
Synopsis: |
The Food and Drug Administration (FDA) now requires that all clinical trials for drugs that affect the central nervous system--including psychiatric drugs--are assessed for whether that drug might cause suicidal ideation or behavior. The Institute of Medicine's (IOM) Forum on Neuroscience and Nervous System Disorders hosted a meeting on June 26, 2009, to discuss the FDA's new policy and how to analyze best whether suicidal thoughts predict actual suicidal behavior in the near future. |
Publication: |
US |
Imprint: |
National Academies Press |
Returns: |
Returnable |